๐Ÿ•ต๏ธ Takeda Pharmaceutical Company Limited ($TAK)

SEC insider & ownership activity, last 12 months ยท CIK 1395064 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. 12 planned sales are pending, the largest $3.0M (Andrew Plump). No red-flag 8-Ks in the window.

๐Ÿšจ 3 signals active โ€” planned-vs-executed verdicts, pre-event flags, and cluster context live in the API and the alerts bot.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Marcello Pignagnoli Agosti$417KJul 13, 2026 filing โ†—
Lauren Rusckowski Duprey$864KJul 13, 2026 filing โ†—
Giles Platford$564KJul 13, 2026 filing โ†—
Natalie Furney$560KJul 13, 2026 filing โ†—
Gabriele Ricci$456KJul 13, 2026 filing โ†—
Nicola Greenway$123KJul 13, 2026 filing โ†—
Elaine Shannon$72KJul 13, 2026 filing โ†—
Ramy Riad$132KJul 13, 2026 filing โ†—
Awny Farajallah$254KJul 13, 2026 filing โ†—
Rhonda Pacheco$307KJul 13, 2026 filing โ†—
Andrew Plump$3.0MJul 13, 2026 filing โ†—
Teresa Bitetti$908KJul 13, 2026 filing โ†—
Julie Kim$1.6MJul 13, 2026 filing โ†—
Lauren Rusckowski Duprey$421KDec 9, 2025 filing โ†—
Teresa Marie Bitetti$1.2MDec 5, 2025 filing โ†—
Giles Richard Platford$836KDec 4, 2025 filing โ†—

Material events (8-K)

No 8-K filings in the last 12 months.